By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Dyadic today announced it has raised $3 million through a private placement of convertible subordinated secured promissory notes to five undisclosed investors.

The Jupiter, Fla.-based firm expects to use proceeds from the funding for working capital, including investments in R&D, new product launches, and general corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.